Dumont & Blake Investment Advisors LLC Regenerx Biopharmaceuticals Inc Transaction History

Dumont & Blake Investment Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 03, 2021	SELL	$0.25 - $0.75 $5,575 - $16,725	-22,300 Closed	0 $0
Q1 2018 Apr 26, 2018	SELL	$0.2 - $0.29 $7,662 - $11,110	-38,312 Reduced 63.21%	22,300 $5,000
Q4 2017 Feb 15, 2018	BUY	$0.15 - $0.37 $3,000 - $7,400	20,000 Added 49.25%	60,612 $10,000
Q3 2017 Oct 31, 2017	BUY	$0.33 - $0.34 $13,401 - $13,808	40,612	40,612 $13,000

Ticker RGRX
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,550,000
Description
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; ...

Get notified when there are updates to the investment portfolio of Dumont & Blake Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Dumont & Blake Investment Advisors LLC with notifications on news.